Stephen Couban
Halifax, NS, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 24, 2021
Lentivirus-mediated gene therapy for Fabry disease.
Journal: Nature communications
Published: May 05, 2020
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Journal: The Lancet. Haematology
Published: July 31, 2019
Low-depth sequencing for copy number abnormalities in multiple myeloma supersedes fluorescent in situ hybridization in scope and resolution.
Journal: Clinical genetics
Published: February 08, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis.
Journal: Leukemia & lymphoma
Published: January 11, 2019
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.
Journal: Leukemia & lymphoma
Published: October 11, 2018
The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation.
Journal: Experimental hematology
Published: September 05, 2018
A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis.
Journal: Journal of hematology & oncology
Published: July 05, 2018
Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD.
Journal: Bone marrow transplantation
Published: November 20, 2017
Last Updated: 09/26/2026